Author

Norbert Schülke

Observed names: N Schülke, N. Schuelke, N. Schülke, Norbert Schuelke, Norbert Schülke

Observed institutions: Cleveland Clinic, Howard Hughes Medical Institute, Progenics Pharmaceuticals (United States), AlphaVax (United States), Takeda Oncology (United States), Takeda (Japan), University of Regensburg, University of Pennsylvania, Rockefeller University

OpenAlex ID: A5068966647

Works count: 28

Citation count: 2,361

H-index: 18

I10-index: 18